M&A Deal Summary

Integrated DNA Technologies Acquires ArcherDX

On December 20, 2022, Integrated DNA Technologies acquired life science company ArcherDX from Invitae for 48M USD

Acquisition Highlights
  • This is Integrated DNA Technologies’ 3rd transaction in the Life Science sector.
  • This is Integrated DNA Technologies’ largest (disclosed) transaction.
  • This is Integrated DNA Technologies’ 4th transaction in the United States.
  • This is Integrated DNA Technologies’ 1st transaction in Colorado.

M&A Deal Summary
Date 2022-12-20
Target ArcherDX
Sector Life Science
Buyer(s) Integrated DNA Technologies
Sellers(s) Invitae
Deal Type Divestiture
Deal Value 48M USD

Target

ArcherDX

Boulder, Colorado, United States
ArcherDX is a genomic analysis company democratizing precision oncology through a suite of products and services that are highly accurate, personal, actionable, and easy to use in local settings. ArcherDX was formed in 2013 and is headquartered in Boulder, Colorado.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Integrated DNA Technologies

Coralville, Iowa, United States
Category Company
Sector Medical Products
DESCRIPTION

Integrated DNA Technologies, Inc. is a manufacturer of custom nucleic acids (i.e. building blocks of DNA and RNA) and assists researchers in advancing genomics technology, including synthetic biology and Next-Generation Sequencing. The company serves more than 80,000 customers across a diverse set of end markets including academic research, biotechnology, clinical diagnostics and pharmaceuticals.

DEAL STATS #
Overall 7 of 7
Sector (Life Science) 3 of 3
Type (Divestiture) 4 of 4
State (Colorado) 1 of 1
Country (United States) 4 of 4
Year (2022) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-11 Swift Biosciences

Ann Arbor, Michigan, United States

Swift Biosciences, Inc. is a provider in the development of Next-Generation Sequencing (NGS) library preparation genomics kits for academic, translational, and clinical research. Swift Biosciences was founded in 2014 and is based in Ann Arbor, Michigan.

Buy -

Seller(S) 1

SELLER

Invitae

San Francisco, California, United States
Category Company
Founded 2010
Sector Life Science
Employees1,700
Revenue 516M USD (2022)
DESCRIPTION

Invitae is a genetic information company diagnostics for hereditary disorders. Invitae was founded in 2010 and is based in San Francisco, California.

DEAL STATS #
Overall 1 of 3
Sector (Life Science) 1 of 2
Type (Divestiture) 1 of 3
State (Colorado) 1 of 1
Country (United States) 1 of 3
Year (2022) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-07 Ciitizen

Palo Alto, California, United States

Ciitizen is a healthcare technology company helping patients get full control of their medical records to access more personal treatment options including participation in research and clinical trials. Ciitizen was founded in 2017 and is based in Palo Alto, California.

Buy $325M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-11-15 YouScript

Seattle, Washington, United States

YouScript is a clinical decision support and analytics platform. Its software pairs a patient's pharmacogenetic profile with published drug and gene interaction information to assess the risk of adverse drug events and possible side effects. YouScript was established in 2016 and is based in Seattle, Washington.

Sell -
Mergr

Product

Company

Legal